KMT2A is targeted by miR-361-3p and modulates leukemia cell’s abilities to proliferate, migrate and invade

References

• Kayser S, Levis MJ. Clinical implications of molecular markers in acute myeloid leukemia. Eur J Haematol. 2019;102:20–35.
   PubMed Web of Science ®Google Scholar
• Yan R, et al. Ectopic expression of human airway trypsin-like protease 4 in acute myeloid leukemia promotes cancer cell invasion and tumor growth. Cancer Med. 2019;8:2348–2359.
   PubMed Web of Science ®Google Scholar
• Takami A. Hematopoietic stem cell transplantation for acute myeloid leukemia. Int J Hematol. 2018;107:513–518.
   PubMed Web of Science ®Google Scholar
• Langabeer SE. Screening for an underlying myeloproliferative neoplasm in patients with thrombocytosis post-induction chemotherapy for acute myeloid leukemia. Leuk Res Rep. 2020;14:100218. doi:10.1016/j.lrr.2020.100218
   PubMedGoogle Scholar
• Shallis RM, Wang R, Davidoff A, et al. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019;36:70–87.
   PubMed Web of Science ®Google Scholar
• Chen KTJ, Gilabert-Oriol R, Bally MB, et al. Recent treatment advances and the role of nanotechnology, combination products, and immunotherapy in changing the therapeutic landscape of acute myeloid leukemia. Pharm Res. 2019;36:019–2654.
   Web of Science ®Google Scholar
• Liao Q, Wang B, Li X, et al. miRNAs in acute myeloid leukemia. Oncotarget. 2017;8:3666–3682.
   PubMedGoogle Scholar
• Sun Y, et al. miR-1290 promotes proliferation and suppresses apoptosis in acute myeloid leukemia by targeting FOXG1/SOCS3. J Biol Regul Homeost Agents. 2019;33:1703–1713.
   PubMed Web of Science ®Google Scholar
• Liu L, Ren W, Chen K. MiR-34a promotes apoptosis and inhibits autophagy by targeting HMGB1 in acute myeloid leukemia cells. Cell Physiol Biochem. 2017;41:1981–1992.
   PubMed Web of Science ®Google Scholar
• Chen L, et al. Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer. Mol Cancer. 2019 Jan 21;18(1):13. doi:10.1186/s12943-019-0943-0
   PubMed Web of Science ®Google Scholar
• Fletcher CE, et al. Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer. Oncogene. 2019;38:5700–5724.
   PubMed Web of Science ®Google Scholar
• J. Hu, et al. MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma. Cell Death Dis. 2018;9:018–0839.
   PubMed Web of Science ®Google Scholar
• Wallace JA, O'Connell RM. MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts. Blood. 2017;130:1290–1301.
   PubMed Web of Science ®Google Scholar
• Tkachuk DC, Kohler S, Cleary ML. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell. 1992;71:691–700.
   PubMed Web of Science ®Google Scholar
• Mims AS, et al. A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem duplication targeted therapy: results of phase 1 study NCI 8485. Haematologica. 2018;103:982–987.
   PubMed Web of Science ®Google Scholar
• Lee JW, et al. Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPα and GATA-1 in myeloid leukemia with MLL-AF9. Biochem Biophys Res Commun. 2012;426:299–305.
   PubMed Web of Science ®Google Scholar
• Chen CW, Armstrong SA. Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond. Exp Hematol. 2015;43:673–684.
   PubMed Web of Science ®Google Scholar
• Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer. 2007;7:823–833.
   PubMed Web of Science ®Google Scholar
• Ansari KI, Mandal SS. Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing. Febs J. 2010;277:1790–1804.
   PubMed Web of Science ®Google Scholar
• Liu F, et al. TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling. Oncotarget. 2015;6:11585–11599.
   PubMedGoogle Scholar
• Zeng X, et al. Transcriptional activation of ANO1 promotes gastric cancer progression. Biochem Biophys Res Commun. 2019;512:131–136.
   PubMed Web of Science ®Google Scholar
• Ballabio E, Milne TA. Molecular and epigenetic mechanisms of MLL in human leukemogenesis. Cancers. 2012;4:904–944.
   PubMedGoogle Scholar
• Svoboda LK, et al. Tumorigenicity of Ewing sarcoma is critically dependent on the trithorax proteins MLL1 and menin. Oncotarget. 2017;8:458–471.
   PubMedGoogle Scholar
• Sakhdari A, et al. Homogeneously staining region (hsr) on chromosome 11 is highly specific for KMT2A amplification in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Cancer Genet. 2019;238:18–22.
   PubMed Web of Science ®Google Scholar
• Zhang C, et al. KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway. Cell Death Dis. 2017;8:285.
   Web of Science ®Google Scholar
• Sun Y, et al. WDR5 supports an N-Myc transcriptional complex that drives a protumorigenic gene expression signature in neuroblastoma. Cancer Res. 2015;75:5143–5154.
   PubMed Web of Science ®Google Scholar
• Wang H, He H, Yang C. miR-342 suppresses the proliferation and invasion of acute myeloid leukemia by targeting Naa10p. Artif Cells Nanomed Biotechnol. 2019;47:3671–3676.
   PubMed Web of Science ®Google Scholar
• Zheng Z, et al. miR-183-5p inhibits occurrence and progression of acute myeloid leukemia via targeting erbin. Mol Ther. 2019;27:542–558.
   PubMed Web of Science ®Google Scholar
• Ying X, Zhang W, Fang M, et al. miR-345-5p regulates proliferation, cell cycle, and apoptosis of acute myeloid leukemia cells by targeting AKT2. J Cell Biochem. 2018;2:27461.
   Google Scholar
• Liu J, Zhu J, Xiao Z, et al. BBOX1-AS1 contributes to colorectal cancer progression by sponging hsa-miR-361-3p and targeting SH2B1. FEBS Open Bio. 2020;27:2211–5463.
   Google Scholar
• Li X, Zheng H. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis. Thorac Cancer. 2020;11:295–304.
   PubMed Web of Science ®Google Scholar
• Hua B, et al. MicroRNA-361-3p promotes human breast cancer cell viability by inhibiting the E2F1/P73 signalling pathway. Biomed Pharmacother. 2020;125(:25):109994. doi:10.1016/j.biopha.2020.109994
   PubMedGoogle Scholar